Format

Send to

Choose Destination
Am J Trop Med Hyg. 2011 Aug;85(2):291-4. doi: 10.4269/ajtmh.2011.11-0056.

Adverse events after mass azithromycin treatments for trachoma in Ethiopia.

Author information

1
The Carter Center, Addis Ababa, Ethiopia.

Abstract

During a cluster-randomized clinical trial for trachoma in Ethiopia, two rounds of adverse event surveillance were performed in a random sample of communities after community-wide mass azithromycin treatment. The prevalence of any reported adverse event ranged from 4.9% to 7.0% in children 1-9 years of age and from 17.0% to 18.7% in persons ≥ 10 years of age. Adverse events appeared to cluster by household and perhaps by village. Mass azithromycin distributions were well tolerated in this setting.

PMID:
21813850
PMCID:
PMC3144828
DOI:
10.4269/ajtmh.2011.11-0056
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Ingenta plc Icon for PubMed Central
Loading ...
Support Center